Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Holmberg

Showing results (401-410 of 509) with videos related to

Pageof 51
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMFJ Andersson, L Larsson, S Klaar, et al.
Epidemiology and Infection|February 26, 2004
EHEC outbreak among staff at a children's hospital--use of PCR for verocytotoxin detection and PFGE for epidemiological investigationC Welinder-Olsson, K Stenqvist, M Badenfors, et al.
Kidney International|March 11, 2006
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndromeF Vaziri-Sani, L Holmberg, A G Sjöholm, et al.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53T Norberg, T Jansson, S Sjøgren, et al.
American Journal of Veterinary Research|January 1, 1993
Clinical pathologic profiles of dogs and turkeys with congestive heart failure, either noninduced or induced by rapid ventricular pacing, and turkeys with furazolidone toxicosisP J O'Brien, M O'Grady, J H Lumsden, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|December 4, 2009
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohortE Niméus-Malmström, A Koliadi, C Ahlin, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
Cancer Epidemiology|September 13, 2011
A comparison of prostate cancer survival in England, Norway and Sweden: a population-based studyL Holmberg, D Robinson, F Sandin, et al.
Pageof 51

Showing results (401-410 of 509) with videos related to

Sort By:
Pageof 51
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMFJ Andersson, L Larsson, S Klaar, et al.
Epidemiology and Infection|February 26, 2004
EHEC outbreak among staff at a children's hospital--use of PCR for verocytotoxin detection and PFGE for epidemiological investigationC Welinder-Olsson, K Stenqvist, M Badenfors, et al.
Kidney International|March 11, 2006
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndromeF Vaziri-Sani, L Holmberg, A G Sjöholm, et al.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53T Norberg, T Jansson, S Sjøgren, et al.
American Journal of Veterinary Research|January 1, 1993
Clinical pathologic profiles of dogs and turkeys with congestive heart failure, either noninduced or induced by rapid ventricular pacing, and turkeys with furazolidone toxicosisP J O'Brien, M O'Grady, J H Lumsden, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|December 4, 2009
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohortE Niméus-Malmström, A Koliadi, C Ahlin, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
Cancer Epidemiology|September 13, 2011
A comparison of prostate cancer survival in England, Norway and Sweden: a population-based studyL Holmberg, D Robinson, F Sandin, et al.
Pageof 51